C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/1997
11/27/1997	CA2227171A1 Icea gene and related methods
11/26/1997	EP0808902A2 Novel genes encoding antiviral proteins of Phytolacca insularis Nakai and recombinant microorganisms expressing the same proteins
11/26/1997	EP0808901A2 Pharmaceutical preparation with factor VIII procoagulant activity and vWF-binding activity
11/26/1997	EP0808900A2 Polynucleotides and polypeptides associated with benign prostatic hypertrophy
11/26/1997	EP0808899A2 Human marco scavenger receptor (HMarcoSR)
11/26/1997	EP0808897A1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines
11/26/1997	EP0808846A2 Peptides which react with antiboby representing the prognostic marker for HIV disease progression
11/26/1997	EP0808630A1 Cancer control
11/26/1997	EP0808375A1 Lil-stat dna binding sites and methods for identifying inhibitory binding agents
11/26/1997	EP0808374A1 Method for modulating processes mediated by farnesoid activated receptors
11/26/1997	EP0808370A1 Stress-tolerant plants and methods of producing the same
11/26/1997	EP0808369A1 GnRH-LEUKOTOXIN CHIMERAS
11/26/1997	EP0808367A1 Mucosal vascular addressins and uses thereof
11/26/1997	EP0808366A1 IDENTIFICATION OF DEC, (DENTRITIC AND EPITHELIAL CELLS, 205 kDa), A RECEPTOR WITH C-TYPE LECTIN DOMAINS, NUCLEIC ACIDS ENCODING DEC, AND USES THEREOF
11/26/1997	EP0808365A1 Human interleukin-1 receptor accessory protein
11/26/1997	EP0808364A1 Human pancreatic cell lines: developments and uses
11/26/1997	EP0808361A1 Novel replication process
11/26/1997	EP0808351A2 Cytoplasmic antiproteinase-2 and cytoplasmic antiproteinase-3 and coding sequences
11/26/1997	EP0808332A1 Method for preparing collagen from cnidarians, and resulting cosmetic compositions
11/26/1997	EP0808324A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease
11/26/1997	EP0808323A1 MUTANTS OF THE Rb AND p53 GENES AND USES THEREOF
11/26/1997	EP0808321A1 InK4c-p18 AND InK4D-p19, INHIBITORS OF CYCLIN-DEPEDENT KINASES CDK4 AND CDK6, AND USES THEREOF
11/26/1997	EP0808169A1 Programmed cell death genes and proteins
11/26/1997	EP0763113A4 Genetic sequences conferring disease resistance in plants and uses therefor
11/26/1997	EP0755451A4 Materials and methods for management of hyperacute rejection in human xenotransplantation
11/26/1997	EP0687307A4 Inhibition of tax-mediated increase in dna binding
11/26/1997	EP0662130B1 A method of producing hepatocyte growth factor and a cell line
11/26/1997	EP0580829B1 Bacterial protein extract, process for preparing the same and pharmaceutical composition containing said extract
11/26/1997	EP0542863B1 Expression of recombinant polypeptides with improved purification
11/26/1997	EP0482176B1 Monoclonal antibodies specific for toxin b of clostridium difficile
11/26/1997	EP0466816B1 Method for enhancing transmembrane transport of exogenous molecules
11/26/1997	CN1165859A Enhanced accummulation of trehalose in plants
11/26/1997	CN1036532C Process for preparing non-glycosylated recombining human IL2 in reduced form
11/25/1997	US5691461 Oligonucleotides inhibiting candida germ tube formation
11/25/1997	US5691460 Epidermal surface antigen gene
11/25/1997	US5691455 Gonadotropins with non-native disulfide bridges
11/25/1997	US5691454 APC antibodies
11/25/1997	US5691453 Blood substitutes
11/25/1997	US5691452 Method for preserving a hemoglobin blood substitute
11/25/1997	US5691451 Method for sterilizing recombinant human serum albumin pharmaceutical preparation
11/25/1997	US5691449 Respiratory syncytial virus vaccines
11/25/1997	US5691448 Glutamic acid decarboxylase protein for autoantibody binding to epitopes
11/25/1997	US5691447 GC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies
11/25/1997	US5691317 Antisense oligonucleotides of human regulatory subunit RI-alpha of cAMP dependent protein kinases for the treatment of cancer
11/25/1997	US5691313 Methods of treating impotency with ciliary neurotrophic factor
11/25/1997	US5691311 Methods for coating invasive devices with inhibitors of thrombin
11/25/1997	US5691309 Reduce fat tissue; polypeptide
11/25/1997	US5691308 Polypeptide insecticide
11/25/1997	US5691306 Protein secretion
11/25/1997	US5691200 Culture product
11/25/1997	US5691199 DNA encoding biocidal proteins
11/25/1997	US5691197 Isolated DNA sequence for a novel macrophage receptor with a collagenous domain
11/25/1997	US5691196 Recombinant nucleic acid containing a response element
11/25/1997	US5691189 Saccharomyces cerevisiae expressing M2 protein of influenza A virus
11/25/1997	US5691188 Genetic engineering
11/25/1997	US5691186 Filariid cysteine protease genes
11/25/1997	US5691183 CD4+ T-lymphoctye proteases and genes encoding said proteases
11/25/1997	US5691179 Polynucleotide
11/25/1997	US5691177 Lymphocytes and genetic vectors for treatment of cancer or autoimmune diseases
11/25/1997	US5691176 Recombinant adeno-associated virus vector packaging cells and methods for use
11/25/1997	US5691175 Immortalized human fetal osteoblastic cells
11/25/1997	US5691170 Generation of hybrid genes and proteins by virus-mediated recombination
11/25/1997	US5691169 Process for preparing a desired protein
11/25/1997	US5691168 DNA sequences encoding AlaGlu-IGF-1 and vectors and microorganisms comprising said sequences
11/25/1997	US5691167 DNA encoding allergenic proteins and peptides from Johnson grass pollen
11/25/1997	US5691166 Gene expression for genetic engineering using dna for plasmids
11/25/1997	US5691157 Method for detecting a mammal's prior exposure to radiation or radiomimetic chemicals
11/25/1997	US5691156 Method of inhibiting cell growth with the P2U receptor
11/25/1997	US5691155 Detectors, vectors, gene expression
11/25/1997	US5691152 Stable avidin composition
11/25/1997	US5691147 Observing complexing of cyclin dependent kinase with a binding protein, use as screening method for inhibitors
11/25/1997	US5691144 Methods of detecting novel mutations relating to X-linked Charcot-Marie-Tooth disease
11/25/1997	US5691142 Cleaving a nucleic acid cleavage structure in a site-specific manner
11/25/1997	US5691137 Methods of screening candidate agents for biological activity using yeast cells
11/25/1997	US5690941 Molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a protein produced by P. falciparum at the sporozoite stage and in the hepatocytes
11/25/1997	US5690939 Immunizing poultry
11/25/1997	US5690938 Oral immunization with multiple particulate antigen delivery system
11/25/1997	US5690937 Temperature sensitive clustered changed-to-alanine mutants of influenza virus PB2 gene
11/25/1997	US5690934 Peptides relating to the extracellular membrane-bound segment of human alpha chain
11/25/1997	US5690928 Administering transforming growth factor
11/25/1997	US5690925 Polypeptide
11/25/1997	US5690905 Peptide-metal ion pharmaceutical labeling method
11/25/1997	CA2099865C Hepatic growth factor receptor is the met proto-oncogene
11/24/1997	CA2205824A1 Pharmaceutical preparation with factor viii procoagulant activity and vwf binding activity
11/23/1997	CA2186303A1 Novel genes encoding antiviral proteins of phytolacca insularis nakai and recombinant microorganisms expressing the same proteins
11/22/1997	CA2205077A1 Peptides which react with antibody representing the prognostic marker for hiv disease progression
11/20/1997	WO1997043649A1 CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrPc AND PrP?sc¿
11/20/1997	WO1997043647A1 Dp and e2f protein nuclear localisation signals and their use
11/20/1997	WO1997043436A1 A process for producing a recombinant polypeptide involving the addition of an inhibitor of metal-dependent proteases or chymotrypsins to the cell culture medium
11/20/1997	WO1997043429A1 Plant pathogen resistance genes and uses thereof
11/20/1997	WO1997043428A1 Transgenic plants expressing rabies glycoprotein g, and glycoproteins thus obtained
11/20/1997	WO1997043427A1 Production of apomictic seed
11/20/1997	WO1997043420A1 Method for identifying attenuated chickenpox virus oka strain or strain originating therein and acceptable as attenuated chickenpox vaccine virus
11/20/1997	WO1997043419A2 The spindly gene, methods of identification and use
11/20/1997	WO1997043418A1 Globulin protein 11s, usable as a seed impregnation marker during germination.
11/20/1997	WO1997043417A1 Cortistatin: neuropeptides, compositions and methods
11/20/1997	WO1997043416A1 Common gamma chain blocking agents
11/20/1997	WO1997043415A1 Cyclin d binding factor, and uses thereof
11/20/1997	WO1997043414A2 A basal cell carcinoma tumor suppressor gene
11/20/1997	WO1997043413A1 Heavy chain member of the kinesin family human homolog

1 ... 2434 2435 2436 2437 2438 2439 2440 2441 2442 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 ... 2916